A fair question Tuts. I would like to be in a position to have...

A fair question Tuts. I would like to be in a position to have the choice of selling shares for a reasonable return - after 12 years and chipping in every capital raise....90c maybe/maybe not. Would still be less than $1 billion MC.

We often hear:- 'step change', 'value inflection points' and 'its all about the data'...' well the primary data in our primary trial is in and the inflection point is also in but not in the direction that 'create's value to the long term shareholders.

I want to see big pharma come in with $$$ put your money on the table - partnership/license or take-out completely (sorry Tuts thats how I feel). Its all well and good entering into several collaborations with BP when it doesn't cost them anything (other than product - at cost). All the risk and cost is with us.

So Mr Merck(s) come on down and bring your wallet...or Mrs BMS - lets dance the AIPAC waltz (really showing my age now!).

The time has come Marc - data(s) are in - no more step change - step up is what's needed.